QLGN News and Press, Qualigen Therapeutics Inc. From 12/16/20

Qualigen Therapeutics, Inc. Announces $12 Million Registered Direct Offering CARLSBAD, Calif. , Dec. 16, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) ("Qualigen" or the "Company"), today announced it has entered into a definitive agreement wi...

Are These Small-Cap Stocks On Your December Watch List? Small-cap stocks are crushing milestones in 2020, which is why so many are looking for penny stocks to buy right now. While not all penny stocks are considered small caps, a good benchmark of health is the Russell 2000 ETF ...

Qualigen Therapeutics ([[QLGN]] +10.7%) announces that the United States Patent and Trademark Office has issued a patent related to its ALAN (Aptamer-Linked Anti-Nucleolin) technology.This patent issued protects the ALAN technology for use with cancer radiation therapy and for imaging tu...

Qualigen Therapeutics Announces Issuance of U.S. Patent for Expanded Applications of ALAN Anticancer Platform Technology CARLSBAD, Calif. , Dec. 15, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing no...

Penny Stocks to Watch Today Finding the best penny stocks to buy seems simple, but it takes time to identify a clear trend. We saw this week, how quickly these can breakout. We’ve also seen how quickly they can break down. So deciding what type of trading strategy you’...

Immutep (IMMP) +132% after breast cancer trial shows promising survival data.Greenwich LifeSciences (GLSI) +57%.UTStarcom Holdings (UTSI) +50%.Panbela Therapeutics (PBLA) +46%.Leju Holdings (LEJU) +38%.SELLAS Life Sciences (SLS) +36%.ClearOne (CLRO) +35% to expand its footprint in M...

Cancer Stocks Are Surging This Week Cancer penny stocks took off this week thanks to a little help from one of the small caps making headlines. This morning, Greenwich LifeSciences ( GLSI Stock Report ) announced big news on its cancer treatment candidate. A poster presentat...

Qualigen Therapeutics Announces Board Member Amy Broidrick as EVP, Chief Strategy Officer and Names Sidney Emery, Jr. to its Board CARLSBAD, Calif. , Dec. 8, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developin...

Qualigen Therapeutics Completes Recertification of Existing AS1411 Drug Supply for Use in Upcoming Clinical Trials CARLSBAD, Calif. , Dec. 2, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN) announces that it has completed the recertification of i...

Qualigen Therapeutics (QLGN): FQ2 GAAP EPS of -$0.41 misses by $0.61.Revenue of $0.84M (-30.0% Y/Y) misses by $0.75M.Press Release For further details see: Qualigen Therapeutics EPS misses by $0.61, misses on revenue